臨床試驗

MagDI Australia Study

NCT：NCT06473831 · COMPLETED

NCT IDNCT06473831

狀態COMPLETED

開始日期2024-08-13

完成時間2026-06-25

SponsorGT Metabolic Solutions, Inc. (INDUSTRY)

First posted2024-06-25

Last updated2026-09-11

簡要摘要

The objective of the MagDI Australia Study is to evaluate the feasibility / performance, safety, and initial efficacy of the MagDI System in eligible participants who are indicated for a duodeno-ileal (small bowel) side-to-side anastomosis procedure for partial intestinal diversion (e.g., one example of a small bowel clinical procedure requiring a side-to-side anastomosis).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。